The ImageKids Study: Developing the pMEDIC and the PICMI

Summary

The overall objectives of this study are to develop two indices capable of measuring intestinal damage, and, separately, inflammatory disease activity in Pediatric Crohn's disease by means of Magnetic Resonance Imaging with Enterography protocol (MRE) and pelvic MRI.

Conditions

• Crohn's Disease

Interventions

DEVICE

MRE

Developing the Pediatric Crohn's Disease Intestinal Damage Score (pMEDIC score) and the Pediatric MRE-Based Activity Index (PICMI)

Sponsors & Collaborators

• Children's Hospital of Eastern Ontario

  collaborator OTHER

• McMaster Children's Hospital

  collaborator OTHER

• IWK Health Centre

  collaborator OTHER

• Alberta Children

  collaborator UNKNOWN

• The Hospital for Sick Children

  collaborator OTHER

• Children's Hospital of Philadelphia

  collaborator OTHER

• Connecticut Children's Medical Center

  collaborator OTHER

• Nationwide Children's Hospital

  collaborator OTHER

• Children's Hospital Medical Center, Cincinnati

  collaborator OTHER

• Hasbro Children's Hospital

  collaborator OTHER

• C.S. Mott Children's Hospital

  collaborator OTHER

• Hospital Sant Joan de Deu

  collaborator OTHER

• Hospital Materno-Infantil de Málaga

  collaborator OTHER

• Hôpital Necker-Enfants Malades

  collaborator OTHER

• Erasmus Medical Center

  collaborator OTHER

• Leiden University Medical Center

  collaborator OTHER

• Yorkhill Hospital

  collaborator UNKNOWN

• Dr. von Hauner Children's Hospital

  collaborator OTHER

• Klinikum Stuttgart

  collaborator OTHER

• Royal Children's Hospital

  collaborator OTHER

• Sydney Children's Hospitals Network

  collaborator OTHER

• Sheba Medical Center

  collaborator OTHER_GOV

• Soroka University Medical Center

  collaborator OTHER

• Rambam Health Care Campus

  collaborator OTHER

• Schneider Children

  collaborator UNKNOWN

• Shaare Zedek Medical Center

  lead OTHER

Principal Investigators

• Dan Turner · Shaare Zedek Medical Center

Study Design

Allocation

NON_RANDOMIZED

Purpose

DIAGNOSTIC

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

5 Years

Max Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2013-01-31

Primary Completion

2017-03-31

Completion

2017-03-31

Countries

• Israel

Study Locations